John P. Butler serves as Executive at Akebia Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, John P. Butler has executed 56 insider transactions totaling $1.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 22, 2014 involved purchasing 1,000 shares valued at $11.9K.
John P. Butler currently holds 2,044,580 shares of Akebia Therapeutics, Inc. (AKBA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John P. Butler has been a net seller of AKBA stock. They have purchased $484.7K and sold $733.8K worth of shares.
John P. Butler's most recent insider trade was on Dec 22, 2014, when they purchased 1,000 shares at $11.92 per share.
Get notified when new Form 4 filings are submitted
| $11.34 |
| Discretionary |
| Nov 12, 2014 | AKBA | $10.3K | Purchase | 1,000 | $10.31 | Discretionary |
| Nov 11, 2014 | AKBA | $14.3K | Option Exercise | 30,500 | $0.47 | Discretionary |
| Jun 19, 2014 | RLYP | $0 | Award | 2,712 | $N/A | Discretionary |
| Mar 25, 2014 | AKBA | $235.4K | Purchase | 13,850 | $17.00 | Discretionary |